Patents by Inventor Scott Lonning

Scott Lonning has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of myocardial infarction using TGF-? antagonists
    Patent number: 10633437
    Abstract: Disclosed herein is a method of treating a patient suffering a myocardial infarction, particularly an acute myocardial infarction, or of reducing an adverse consequence of a myocardial infarction in a patient comprising administering an antagonist of TGF-? to the patient during the acute stage of the myocardial infarction.
    Type: Grant
    Filed: December 12, 2016
    Date of Patent: April 28, 2020
    Assignee: GENZYME CORPORATION
    Inventors: Geoffrey Y. Akita, Scott Lonning, Richard C Gregory, Jr., Amelia B Kudej
  • Combination therapy for treating breast cancer
    Patent number: 10507242
    Abstract: The invention provides compositions and methods for treating breast cancer. Specifically, the invention relates to administering a Transforming Growth Factor beta (TGF?) antagonist in combination with capecitabine and ixabepilone to treat breast cancer.
    Type: Grant
    Filed: January 9, 2017
    Date of Patent: December 17, 2019
    Assignee: GENZYME CORPORATION
    Inventors: Jay Harper, Scott Lonning, Frank Hsu
  • COMBINATION THERAPY FOR TREATING BREAST CANCER
    Publication number: 20170319691
    Abstract: The invention provides compositions and methods for treating breast cancer. Specifically, the invention relates to administering a Transforming Growth Factor beta (TGF?) antagonist in combination with capecitabine and ixabepilone to treat breast cancer.
    Type: Application
    Filed: January 9, 2017
    Publication date: November 9, 2017
    Inventors: JAY HARPER, Scott LONNING, Frank HSU
  • TREATMENT OF MYOCARDIAL INFARCTION USING TGF BETA ANTAGONISTS
    Publication number: 20170233465
    Abstract: Disclosed herein is a method of treating a patient suffering a myocardial infarction, particularly an acute myocardial infarction, or of reducing an adverse consequence of a myocardial infarction in a patient comprising administering an antagonist of TGF-? to the patient during the acute stage of the myocardial infarction.
    Type: Application
    Filed: December 12, 2016
    Publication date: August 17, 2017
    Applicant: Genzyme Corporation
    Inventors: Geoffrey Y. AKITA, Scott Lonning, Richard C. Gregory, JR., Amelia B. Kudej
  • Combination therapy for treating breast cancer
    Patent number: 9539325
    Abstract: The invention provides compositions and methods for treating breast cancer. Specifically, the invention relates to administering a Transforming Growth Factor beta (TGF?) antagonist in combination with capecitabine and ixabepilone to treat breast cancer.
    Type: Grant
    Filed: December 5, 2014
    Date of Patent: January 10, 2017
    Assignee: Genzyme Corporation
    Inventors: Jay Harper, Scott Lonning, Frank Hsu
  • COMBINATION THERAPY FOR TREATING BREAST CANCER
    Publication number: 20150086547
    Abstract: The invention provides compositions and methods for treating breast cancer. Specifically, the invention relates to administering a Transforming Growth Factor beta (TGF?) antagonist in combination with capecitabine and ixabepilone to treat breast cancer.
    Type: Application
    Filed: December 5, 2014
    Publication date: March 26, 2015
    Inventors: Jay HARPER, Scott LONNING, Frank HSU
  • TREATMENT OF MYOCARDIAL INFARCTION USING TGF BETA ANTAGONISTS
    Publication number: 20130330352
    Abstract: Disclosed herein is a method of treating a patient suffering a myocardial infarction, particularly an acute myocardial infarction, or of reducing an adverse consequence of a myocardial infarction in a patient comprising administering an antagonist of TGF-? to the patient during the acute stage of the myocardial infarction.
    Type: Application
    Filed: September 1, 2011
    Publication date: December 12, 2013
    Applicant: Genzyme Corporation
    Inventors: Geoffrey Y Akita, Richard Gregory, Scott Lonning, Amelia Kudel